Merck (MRK) capital expenditure was $4.1B in FY2025 (+22% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$4.1B
+22%
2024
$3.4B
-13%
2023
$3.9B
-12%
2022
$4.4B
-1%
2021
$4.4B
+0%
2020
$4.4B
+31%
2019
$3.4B
+29%
2018
$2.6B
+39%
2017
$1.9B
+17%
2016
$1.6B
+26%
2015
$1.3B
-45%
2014
$2.3B
+50%
2013
$1.5B
-21%
2012
$2.0B
+13%
2011
$1.7B
+3%
2010
$1.7B
+15%
2009
$1.5B
+13%
2008
$1.3B
+28%
2007
$1.0B
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q1 2026
$991M
Q4 2025
$1.0B
Q3 2025
$987M
Q2 2025
$764M
Q1 2025
$1.3B
Q4 2024
$937M
Q3 2024
$783M
Q2 2024
$791M
Q1 2024
$861M
Q4 2023
$989M
Q3 2023
$902M
Q2 2023
$965M
Source: MRK on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.